Skip to main content

Table 1 Baseline demographics and ocular characteristics

From: Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis

Demographics Baseline
 Eyesa (right:left) 20 (11:9)
 Average age at screening 63.7 (45–78)
 Gender (female:male) 13:7
 Average prior injectionsb 4.25
ETDRS scores: average (range)
 Study eye 69.95 (60–81)
 Fellow eye 73.65 (37–85)
Diabetic retinopathy severity
 Mild 0
 Moderate 9
 Severe 5
 PDR 6
OCT values
 Study eye
  CST [Mean (range)] 419.7 (328–585)
  Cube volume [Mean (range)] 11.55 (9.1–13.9)
  Cube average thickness [Mean (range)] 320.7 (253–386)
 Fellow eye
  CST [Mean (range)] 300.40 (181–432)
  Cube volume [Mean (range)] 10.81 (8.8–12.8)
  Cube average thickness [Mean (range)] 300.20 (246–354)
  1. aOnly one eye per patient, bon the 6 month prior enrollment
  2. CST central subfield thickness, ETDRS early treatment diabetic retinopathy study, OCT optical coherence tomography